ENG 繁 简
E Fund (HK) NASDAQ-100 Index Fund
Important Notes Fund Information Portfolio Allocation Performance Distribution History Announcements Notices Documents Distributors
Investment Objective and Strategy
Objective

The investment objective of the Sub-Fund is to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the NASDAQ-100 Index (the “Index”). There is no assurance that the Sub-Fund will achieve its investment objective.
Strategy

In seeking to achieve the Sub-Fund's investment objective, the Manager will primarily use a full replicationstrategy through investing in substantially all the Index securities constituting the Index (the "Index Securities")in substantially the same weightings (i.e. proportions) as these Index securities have in the Index. Such IndexE Fund (HK) NASDAQ-100 Index Fund4Securities may include securities of non-financial companies (which may include listed depositary receipts suchas American Depositary Receipts ("ADRs") which are listed on the NASDAQ.


The Manager may however, in the exceptional circumstances (i.e. due to restrictions, suspensions of trading,limited availability of certain Index Securities, corporate events, or as the Manager believes there is significantmarket mispricing or foreseeable market turbulence) where it is not feasible or not in the best interest of investorsto acquire certain securities which are constituents of the Index and/or it is not cost efficient, by reference to theSub-Fund's NAV, use a representative sampling strategy where the Manager believes will help the Sub-Fundachieve its investment objective.


In pursuing the representative sampling strategy, the Manager may:


  1. invest in a representative sample whose performance is closely correlated with the Index, but whoseconstituents may or may not themselves be constituents of the Index;

  2. invest less than 30% of the Net Asset Value of the Sub-Fund in other collective investment schemes("CIS"), each being either an exchange traded fund or an unlisted index tracking fund which tracksan index that has a high correlation with the Index. Such CIS may be authorised by the SFC, eligibleschemes under Chapter 7.11A of the Code, or non-eligible schemes. For the avoidance of doubt,the Sub-Fund's aggregate investment in non-eligible schemes and not authorised by the SFC maynot exceed 10% of the NAV of the Sub-Fund; and

  1. invest in financial derivative instruments ("FDIs") which exhibit high correlation with the Index,including futures and swaps where the Manager believes such investments will help the Sub-Fundachieve its investment objective and are beneficial to the Sub-Fund. For the avoidance of doubt, theaggregate investment in futures and swaps will be less than 30% of the Sub-Fund's NAV.

In pursuing the representative sampling strategy, the Manager may cause the Sub-Fund to deviate from the indexweighting on condition that the maximum deviation from the index weighting of any constituent will not exceed3% or such other percentage as determined by the Manager after consultation with the SFC.


Investors should note that the Manager may switch between the full replication and representative samplingstrategies without notice to investors and in its absolute discretion.


The Sub-Fund may also utilise FDIs for hedging purposes to the extent permitted by Chapter 7 of the Code.


Securities Lending

The Manager may, on behalf of the Sub-Fund, enter into Securities Lending Transactions, with the maximumlevel for up to 50% and expected level for approximately 20% of its NAV, and is able to recall the securities lentout at any time. As part of the securities lending transactions, the Sub-Fund must receive cash and/or non-cashcollateral of at least 100% of the value of the securities lent (interests, dividends and other eventual rightsincluded). The collateral will be marked-to-market on a daily basis and be safekept by the Custodian. AllSecurities Lending Transactions will only be carried out in the best interest of the Sub-Fund and as set out in therelevant securities lending agreement. Such transactions may be terminated at any time by the Manager at itsabsolute discretion1.


The Manager does not currently intend to enter into Sale and Repurchase Transactions, Reverse RepurchaseTransactions and other similar over-the-counter transactions on behalf of the Sub-Fund. The Manager will seekprior approval of the SFC (to the extent required under applicable regulatory requirements) and provide at leastone month's prior notice to Shareholders before the Manager engages in any such transactions.


Index

The Index is a modified market capitalisation weighted index, whereby the weights of Index Securities are basedon their market capitalisations, but with certain rules capping the weights of the Index Securities. It includes 100of the largest US and international non-financial companies listed on the Nasdaq based on market capitalisation,and reflects companies across major industry groups including computer hardware and software,telecommunications, retail/wholesale trade and biotechnology, and does not contain securities of financialcompanies. The Index is calculated and disseminated in USD.


The Index is calculated and maintained by NASDAQ, Inc. or its affiliates (the "Index Provider"). The Manager(and each of its Connected Persons) is independent of the Index Provider.


The Index is a net total return index, which means that it reflects the reinvestment of dividends or distributions,after deduction of any withholding tax.


The Index was launched on 31 January 1985 and had a base level of 125 on the same date. As at 13 January2025, the Index had a net market capitalisation of USD 25.47 trillion and 101 constituents.


On a quarterly basis and an annual basis, the Index will be rebalanced such that the weight of each issuer / IndexSecurity and the collective weight of individual issuers / Index Securities will not exceed the respective thresholdsfurther set out in the Appendix of the Sub-Fund in Part 2 of the Prospectus.


The Index Securities are also reviewed, rebalanced, and reconstituted annually in December.


Further details of the above Index rebalancing and reconstitution processes are set out in the Appendix of theSub-Fund in Part 2 of the Prospectus.

The list of the constituents of the Index and their respective weightings may be accessed at https://www.nasdaq.com/solutions/nasdaq-global-index-policies, whereas additional information and otherimportant news of the Index can be obtained from the website of the Index Provider athttps://indexes.nasdaq.com/Index/Overview/NDX. (The contents of the foregoing websites have not beenreviewed by the SFC).


Reuters: .XNDXNNR

Bloomberg: XNDXNNR

Fund Information
HKD
RMB
USD
Class A (Acc) HKD
Class A (Acc) RMB
Class A (Acc) USD
Manager
Inception Date
Base Currency
Management Fee (p.a.) *
(% Net Asset Value of the Sub-Fund per annum)
Subscription Fee
Switching Fee
Performance Fee
Custodian Fee
Redemption Fee
Dealing & Trading Frequency
Current NAV Per Unit ()
as of 16 Oct,2025
Custodian
Historical NAV
Download
ISIN
Bloomberg Ticker
*Please note that these fees may be increased up to a permitted maximum on giving 1 month’s notice to unitholders. Please refer to the section of the prospectus entitled “Fees and Expenses” for further details of the fees and charges payable.
Disclaimer

E Fund Management (Hong Kong) Co., Limited is the issuer of this report. This report is neither an offer nor solicitation to purchase units of the fund; applications for units may only be made on forms of application available with the Explanatory Memorandum. Investments are subject to investment risks, fund value may go up as well as down and past performance is not indicative of future performance. Investors should read carefully the Explanatory Memorandum (including the section “Risk Factors”) for the relevant risks associated with the investment in the fund before investing.
Distribution of this report may be restricted in certain jurisdictions. This report does not constitute the distribution of any information or the making of any offer or solicitation by anyone in any jurisdiction in which such distribution or offer is not authorized or to any person to whom it is unlawful to distribute such a report or make such an offer or solicitation. This report is exempted from pre-vetting and authorization by the Securities and Futures Commission of Hong Kong and has not been reviewed by the Securities and Futures Commission of Hong Kong.
SFC authorization is not a recommendation or endorsement of a scheme nor does it guarantee the commercial merits of a scheme or its performance. It does not mean the scheme is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors.
Copyright© 2025. E Fund Management (Hong Kong) Co., Limited. All rights reserved.


Index Provider Disclaimer
The Product(s) is not sponsored, endorsed, sold or promoted by Nasdaq, Inc. or its affiliates (Nasdaq, with its affiliates, are referred to as the “Corporations”). The Corporations have not passed on the legality or suitability of, or the accuracy or adequacy of descriptions and disclosures relating to, the Product(s). The Corporations make no representation or warranty, express or implied to the owners of the Product(s) or any member of the public regarding the advisability of investing in securities generally or in the Product(s) particularly, or the ability of the NASDAQ-100 Index to track general stock market performance. The Corporations' only relationship to E Fund Management (Hong Kong) Co., Limited (“Licensee”) is in the licensing of the Nasdaq®, and certain trade names of the Corporations and the use of the NASDAQ-100 Index which is determined, composed and calculated by Nasdaq without regard to Licensee or the Product(s). Nasdaq has no obligation to take the needs of the Licensee or the owners of the Product(s) into consideration in determining, composing or calculating the NASDAQ-100 Index . The Corporations are not responsible for and have not participated in the determination of the timing of, prices at, or quantities of the Product(s) to be issued or in the determination or calculation of the equation by which the Product(s) is to be converted into cash. The Corporations have no liability in connection with the administration, marketing or trading of the Product(s).

THE CORPORATIONS DO NOT GUARANTEE THE ACCURACY AND/OR UNINTERRUPTED CALCULATION OF NASDAQ-100 INDEX OR ANY DATA INCLUDED THEREIN. THE CORPORATIONS MAKE NO WARRANTY, EXPRESS OR IMPLIED, AS TO RESULTS TO BE OBTAINED BY LICENSEE, OWNERS OF THE PRODUCT(S), OR ANY OTHER PERSON OR ENTITY FROM THE USE OF THE NASDAQ-100 INDEX OR ANY DATA INCLUDED THEREIN. THE CORPORATIONS MAKE NO EXPRESS OR IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIM ALL WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE WITH RESPECT TO THE NASDAQ-100 INDEX OR ANY DATA INCLUDED THEREIN. WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT SHALL THE CORPORATIONS HAVE ANY LIABILITY FOR ANY LOST PROFITS OR SPECIAL, INCIDENTAL, PUNITIVE, INDIRECT, OR CONSEQUENTIAL DAMAGES, EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES.